Straits Times Index
3,323.92 -2.36 (-0.07%) Nikkei
39,717.85 +544.70 (+1.39%) Hang Seng
18,064.97 -7.93 (-0.04%) FTSE 100
8,247.79 -33.76 (-0.41%) Bitcoin USD
61,934.91 +661.01 (+1.08%) CMC Crypto 200
1,283.73 +34.60 (+2.77%)
TEVA Dec 2024 12.000 call
- Business Wire
Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020
TEL AVIV, Israel, June 25, 2024--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it has entered an agreement with the Israel Tax Authority (the "ITA") resolving all pending litigation with respect to taxes payable for the Company's taxable years 2008-2020. Under the terms of the agreement the Company will pay a total of $750 million in installments between 2024 to 2029.
- Business Wire
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
PARSIPPANY, N.J., June 24, 2024--Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of an authorized generic of Victoza®1 (liraglutide injection 1.8mg), in the United States.
- Zacks
Here's Why You Should Consider Buying Alvotech (ALVO) Stock
Here, we discuss some reasons why buying Alvotech (ALVO) stock now may turn out to be a prudent move.
